Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3150 | 2232 | 29.7 | 50% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
236 | 3 | ADENOSINE//NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//ADENOSINE RECEPTORS | 48331 |
3150 | 2 | ADENOSINE DEAMINASE//PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY//CECR1 | 2232 |
5370 | 1 | ADENOSINE DEAMINASE//PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY//CECR1 | 1632 |
26087 | 1 | CYTIDINE DEAMINASE//ANTIBIOTIC FUNGICIDE//BLASTICIDIN S | 263 |
29228 | 1 | DRUG DESIGN SYNTH//GUANINE DEAMINASE//ORGANIC SYNTHESIS AND MEDICINAL CHEMISTRY | 190 |
31866 | 1 | EHU MED FISIOL POB 699//RABBIT PARIETAL CELLS//ATP ATP ANALOGS | 147 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ADENOSINE DEAMINASE | authKW | 416675 | 8% | 18% | 169 |
2 | PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY | authKW | 191505 | 1% | 100% | 14 |
3 | CECR1 | authKW | 123110 | 0% | 100% | 9 |
4 | ADENOSINE DEAMINASE DEFICIENCY | authKW | 99267 | 1% | 48% | 15 |
5 | CYTIDINE DEAMINASE | authKW | 85583 | 2% | 17% | 36 |
6 | DRUG DESIGN SYNTH | address | 82726 | 1% | 28% | 22 |
7 | SHIFTING SPECIFICITY MODEL | authKW | 82074 | 0% | 100% | 6 |
8 | ADGF | authKW | 56994 | 0% | 83% | 5 |
9 | GUANINE DEAMINASE | authKW | 55850 | 0% | 58% | 7 |
10 | ANTIBIOTIC FUNGICIDE | authKW | 48850 | 0% | 71% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 2351 | 30% | 0% | 661 |
2 | Immunology | 1154 | 13% | 0% | 279 |
3 | Hematology | 935 | 7% | 0% | 156 |
4 | Medicine, Research & Experimental | 580 | 7% | 0% | 159 |
5 | Oncology | 429 | 9% | 0% | 206 |
6 | Pharmacology & Pharmacy | 401 | 10% | 0% | 231 |
7 | Medical Laboratory Technology | 351 | 2% | 0% | 52 |
8 | Chemistry, Medicinal | 311 | 4% | 0% | 95 |
9 | Biophysics | 208 | 5% | 0% | 103 |
10 | Cell Biology | 153 | 6% | 0% | 142 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG DESIGN SYNTH | 82726 | 1% | 28% | 22 |
2 | DIPARTIMENTO BIOL MCA | 35795 | 1% | 22% | 12 |
3 | EHU MED FISIOL POB 699 | 27358 | 0% | 100% | 2 |
4 | G KH BUNYATYAN BIOCHEM | 18237 | 0% | 67% | 2 |
5 | SCI WOMEN CHILD HLTH | 18237 | 0% | 67% | 2 |
6 | UNITA FISIOL GEN | 18237 | 0% | 67% | 2 |
7 | 1ST INTERNAL MED | 13679 | 0% | 100% | 1 |
8 | ADOLESCENT PEDIAT RHEUMATOL | 13679 | 0% | 100% | 1 |
9 | AIDS UNITHIVACATHOSP CLIN | 13679 | 0% | 100% | 1 |
10 | ARYAN MED | 13679 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 3140 | 1% | 1% | 33 |
2 | NUCLEOSIDES & NUCLEOTIDES | 2939 | 1% | 2% | 12 |
3 | ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY | 1906 | 2% | 0% | 49 |
4 | CANCER RESEARCH THERAPY & CONTROL | 1676 | 0% | 3% | 4 |
5 | ENZYME | 1452 | 0% | 1% | 9 |
6 | LEUKEMIA RESEARCH | 1157 | 1% | 0% | 23 |
7 | COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY | 1079 | 1% | 0% | 28 |
8 | BIOCHEMISTRY | 1078 | 3% | 0% | 68 |
9 | VOPROSY MEDITSINSKOI KHIMII | 980 | 1% | 1% | 13 |
10 | REVISTA ESPANOLA DE FISIOLOGIA | 968 | 0% | 1% | 8 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADENOSINE DEAMINASE | 416675 | 8% | 18% | 169 | Search ADENOSINE+DEAMINASE | Search ADENOSINE+DEAMINASE |
2 | PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY | 191505 | 1% | 100% | 14 | Search PURINE+NUCLEOSIDE+PHOSPHORYLASE+DEFICIENCY | Search PURINE+NUCLEOSIDE+PHOSPHORYLASE+DEFICIENCY |
3 | CECR1 | 123110 | 0% | 100% | 9 | Search CECR1 | Search CECR1 |
4 | ADENOSINE DEAMINASE DEFICIENCY | 99267 | 1% | 48% | 15 | Search ADENOSINE+DEAMINASE+DEFICIENCY | Search ADENOSINE+DEAMINASE+DEFICIENCY |
5 | CYTIDINE DEAMINASE | 85583 | 2% | 17% | 36 | Search CYTIDINE+DEAMINASE | Search CYTIDINE+DEAMINASE |
6 | SHIFTING SPECIFICITY MODEL | 82074 | 0% | 100% | 6 | Search SHIFTING+SPECIFICITY+MODEL | Search SHIFTING+SPECIFICITY+MODEL |
7 | ADGF | 56994 | 0% | 83% | 5 | Search ADGF | Search ADGF |
8 | GUANINE DEAMINASE | 55850 | 0% | 58% | 7 | Search GUANINE+DEAMINASE | Search GUANINE+DEAMINASE |
9 | ANTIBIOTIC FUNGICIDE | 48850 | 0% | 71% | 5 | Search ANTIBIOTIC+FUNGICIDE | Search ANTIBIOTIC+FUNGICIDE |
10 | 2 DEOXYCOFORMYCIN | 47275 | 0% | 31% | 11 | Search 2+DEOXYCOFORMYCIN | Search 2+DEOXYCOFORMYCIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CRISTALLI, G , COSTANZI, S , LAMBERTUCCI, C , LUPIDI, G , VITTORI, S , VOLPINI, R , CAMAIONI, E , (2001) ADENOSINE DEAMINASE: FUNCTIONAL IMPLICATIONS AND DIFFERENT CLASSES OF INHIBITORS.MEDICINAL RESEARCH REVIEWS. VOL. 21. ISSUE 2. P. 105 -128 | 111 | 66% | 150 |
2 | CORTES, A , GRACIA, E , MORENO, E , MALLOL, J , LLUIS, C , CANELA, EI , CASADO, V , (2015) MOONLIGHTING ADENOSINE DEAMINASE: A TARGET PROTEIN FOR DRUG DEVELOPMENT.MEDICINAL RESEARCH REVIEWS. VOL. 35. ISSUE 1. P. 85 -125 | 102 | 29% | 7 |
3 | ANTONIOLI, L , COLUCCI, R , LA MOTTA, C , TUCCORI, M , AWWAD, O , DA SETTIMO, F , BLANDIZZI, C , FORNAI, M , (2012) ADENOSINE DEAMINASE IN THE MODULATION OF IMMUNE SYSTEM AND ITS POTENTIAL AS A NOVEL TARGET FOR TREATMENT OF INFLAMMATORY DISORDERS.CURRENT DRUG TARGETS. VOL. 13. ISSUE 6. P. 842 -862 | 76 | 38% | 21 |
4 | GRUNEBAUM, E , COHEN, A , ROIFMAN, CM , (2013) RECENT ADVANCES IN UNDERSTANDING AND MANAGING ADENOSINE DEAMINASE AND PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCIES.CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY. VOL. 13. ISSUE 6. P. 630-638 | 41 | 64% | 16 |
5 | KLOHS, WD , KRAKER, AJ , (1992) PENTOSTATIN - FUTURE-DIRECTIONS.PHARMACOLOGICAL REVIEWS. VOL. 44. ISSUE 4. P. 459-477 | 81 | 66% | 21 |
6 | ARREDONDO-VEGA, FX , SANTISTEBAN, I , DANIELS, S , TOUTAIN, S , HERSHFIELD, MS , (1998) ADENOSINE DEAMINASE DEFICIENCY: GENOTYPE-PHENOTYPE CORRELATIONS BASED ON EXPRESSED ACTIVITY OF 29 MUTANT ALLELES.AMERICAN JOURNAL OF HUMAN GENETICS. VOL. 63. ISSUE 4. P. 1049-1059 | 42 | 93% | 49 |
7 | HIRSCHHORN, R , (1995) ADENOSINE-DEAMINASE DEFICIENCY - MOLECULAR-BASIS AND RECENT DEVELOPMENTS.CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY. VOL. 76. ISSUE 3. P. S219-S227 | 44 | 94% | 37 |
8 | BOSE, R , NANDAGOPAL, K , (2013) GENETIC AND BIOCHEMICAL CONSEQUENCES OF ADENOSINE DEAMINASE DEFICIENCY IN HUMANS.INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS. VOL. 50. ISSUE 5. P. 345-356 | 26 | 96% | 1 |
9 | TERASAKA, T , (2005) NON-NUCLEOSIDE ADENOSINE DEAMINASE INHIBITORS: 2000-2004.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 15. ISSUE 7. P. 817-828 | 38 | 68% | 2 |
10 | WHITMORE, KV , GASPAR, HB , (2016) ADENOSINE DEAMINASE DEFICIENCY - MORE THAN JUST AN IMMUNODEFICIENCY.FRONTIERS IN IMMUNOLOGY. VOL. 7. ISSUE . P. - | 33 | 59% | 0 |
Classes with closest relation at Level 2 |